WO2001015722A3 - Methods useful in affecting apoptosis - Google Patents

Methods useful in affecting apoptosis Download PDF

Info

Publication number
WO2001015722A3
WO2001015722A3 PCT/US2000/040738 US0040738W WO0115722A3 WO 2001015722 A3 WO2001015722 A3 WO 2001015722A3 US 0040738 W US0040738 W US 0040738W WO 0115722 A3 WO0115722 A3 WO 0115722A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods useful
apoptosis
affecting apoptosis
affecting
compositions
Prior art date
Application number
PCT/US2000/040738
Other languages
French (fr)
Other versions
WO2001015722A2 (en
Inventor
Glenn D Prestwich
Li Feng
Hubert Wojtasek
Original Assignee
Univ Utah Res Found
Glenn D Prestwich
Li Feng
Hubert Wojtasek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found, Glenn D Prestwich, Li Feng, Hubert Wojtasek filed Critical Univ Utah Res Found
Priority to AU80342/00A priority Critical patent/AU8034200A/en
Publication of WO2001015722A2 publication Critical patent/WO2001015722A2/en
Publication of WO2001015722A3 publication Critical patent/WO2001015722A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Abstract

The present invention relates to the field of molecular biology, in particular to apoptosis. The inventors herein disclose compositions and methods useful to alter apoptosis, which compositions and methods enable modification of pathological conditions, such as cancer.
PCT/US2000/040738 1999-08-27 2000-08-25 Methods useful in affecting apoptosis WO2001015722A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU80342/00A AU8034200A (en) 1999-08-27 2000-08-25 Methods useful in affecting apoptosis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15103299P 1999-08-27 1999-08-27
US60/151,032 1999-08-27

Publications (2)

Publication Number Publication Date
WO2001015722A2 WO2001015722A2 (en) 2001-03-08
WO2001015722A3 true WO2001015722A3 (en) 2001-12-13

Family

ID=22537050

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/040738 WO2001015722A2 (en) 1999-08-27 2000-08-25 Methods useful in affecting apoptosis

Country Status (2)

Country Link
AU (1) AU8034200A (en)
WO (1) WO2001015722A2 (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
W. VAN MOLLE ET AL.: "Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins", J. IMMUNOL., vol. 163, 1999, pages 5235 - 5241, XP002164997 *
W. VAN MOLLE ET AL.: "Alpha1-acid glycoprotein and alpha1-antitrypsin inhibit TNF-induced but not anti-Fas inducedapoptosis of hepatocytes in mice", J. IMMUNOL., vol. 159, 1997, pages 3555 - 3564, XP002164996 *

Also Published As

Publication number Publication date
AU8034200A (en) 2001-03-26
WO2001015722A2 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
WO2001076640A3 (en) Chemically modified novel erythropoietin stimulating protein compositions and methods
WO2006093524A3 (en) Antigen-carbohydrate conjugates
WO2003008583A3 (en) Novel compositions and methods for cancer
WO2005027962A3 (en) 4’-thionucleosides and oligomeric compounds
WO2004084453A3 (en) METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES
WO2004063355A3 (en) Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
WO2001036685A3 (en) Differential gene expression in cancer
WO2004044160A3 (en) Muc1 interference rna compositions and methods derived therefrom
WO2004058153A9 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.
AU2002324580A1 (en) Compositions and methods relating to the daptomycin biosynthetic gene cluster
WO2003045230A3 (en) Novel compositions and methods for cancer
WO2002044360A3 (en) Modified arginine deiminase
WO2004087073A3 (en) Treatment of demyelinating conditions
WO2003057146A3 (en) Novel compositions and methods for cancer
WO2002030941A3 (en) Topoisomerase inhibitors
WO2004099388A3 (en) Cbl-b polypeptides, complexes and related methods
WO2003053224A3 (en) Novel compositions and methods for cancer
AU2002341749A1 (en) Methods and compositions for inhibiting the proliferation of prostate cancer cells
WO1999058505A3 (en) Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer
AU2002311859A1 (en) Compositions and methods for treating colorectal polyps and cancer
WO2003035837A3 (en) Novel compositions and methods for cancer
WO2001015722A3 (en) Methods useful in affecting apoptosis
WO2003049696A3 (en) Glucosamine organic acid adducts
WO2004026892A3 (en) Fragmentation of dna
WO2000063366A3 (en) Improved antisense oligomers

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/001866

Country of ref document: MX

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP